Biodefense: DHS Exploring New Methods to Replace BioWatch and Could Benefit from Additional Guidance
Abstract:
Early detection of a biological attack can help reduce illness and loss of life, but DHS has faced challenges in acquiring biodetection capabilities to replace BioWatch, the current system used to detect aerosolized biological attacks. According to DHS, it is exploring the use of a new anomaly detection capability that, if developed successfully, could reduce the time to detection. GAO was asked to examine the BD21 acquisition and assess technical maturity. This report (1) describes BD21 and the extent to which the program has followed DHS's acquisition policy, and (2) examines potential technical challenges to successful BD21 development, and actions to mitigate acquisition risks. GAO analyzed program acquisition documents against DHS acquisition policy and analyzed DHS's TRA guide against GAO's TRA best practices guide. GAO also interviewed DHS and DOD officials familiar with the BD21 acquisition effort for additional context.